Tolerability Comparison of Flarex to Lotemax SM

Clinical trial NCT07588074 · COMPLETED

Trial details

NCT number: NCT07588074
Sponsor: Harrow Inc
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Ocular Inflammation Keratoconjunctivitis Dry Eye Disease (DED)Post-operative Complications Kerato Conjunctivitis Sicca Dry Eye Syndromes Postoperative Complications

Start date: 2021-05-01
Primary completion: 2021-06-30
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.